BCM
CVRS

Bridgeway Capital Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Bridgeway Capital Management’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-56,200
Closed -$241K – 1444
2019
Q3 		$241K Hold
56,200
– – ﹤0.01% 1148
2019
Q2 		$167K Sell
56,200
-635,683
-92% -$1.59M ﹤0.01% 1205
2019
Q1 		$1.2M Sell
691,883
-150,000
-18% -$207K 0.02% 693
2018
Q4 		$707K Buy
841,883
+383,200
+84% +$457K 0.01% 882
2018
Q3 		$651K Hold
458,683
– – 0.01% 1065
2018
Q2 		$379K Hold
458,683
– – ﹤0.01% 1203
2018
Q1 		$628K Buy
458,683
+58,200
+15% +$67.6K 0.01% 1016
2017
Q4 		$404K Hold
400,483
– – ﹤0.01% 1154
2017
Q3 		$609K Sell
400,483
-100,000
-20% -$168K 0.01% 1038
2017
Q2 		$931K Buy
500,483
+109,883
+28% +$146K 0.01% 858
2017
Q1 		$512K Sell
390,600
-100,000
-20% -$81.4K 0.01% 1069
2016
Q4 		$343K Buy
490,600
+390,600
+391% +$329K ﹤0.01% 1198
2016
Q3 		$111K Buy
+100,000
New +$134K ﹤0.01% 1374

Bridgeway Capital Management's CVRS Position: Q4 2019 in Review

Bridgeway Capital Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 56,200 shares — an estimated $241K sold.

Bridgeway Capital Management first reported a position in CVRS in Q3 2016 and held it in 13 quarters. The position peaked at $1.2M in Q1 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.

  • Bridgeway Capital Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
  • Bridgeway Capital Management sold 56,200 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $241K.
  • Bridgeway Capital Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q3 2016 and held it in 13 quarters.
  • Bridgeway Capital Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $1.2M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.

Based on Bridgeway Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.